Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-30 @ 7:11 AM
Study NCT ID:
NCT04998604
Status:
COMPLETED
Last Update Posted:
2025-10-23
First Post:
2021-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-27
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-27
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-09
First Submit QC Date:
None
Study First Post Date:
2021-08-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-10-08
Results First Submit QC Date:
None
Results First Post Date:
2025-10-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-08
Last Update Post Date:
2025-10-23
Last Update Post Date Type:
ESTIMATED